Lifestyle
- Regular exercise
- Avoid alcohol
- Manage stress
ALP · AP · Alkaline Phosphatase
Alkaline Phosphatase measures the activity of the enzyme involved in dephosphorylation, primarily reflecting liver and bone health.
Reference ranges vary with age and sex; higher in children and adolescents due to bone growth.
Alkaline Phosphatase (ALP) is a membrane-bound metalloenzyme that plays a crucial role in dephosphorylation processes, primarily in the liver, bones, kidneys, and bile ducts. It is composed of isoenzymes that originate from different tissues, including liver, bone, intestinal, and placental sources. Researchers have found that ALP is a key marker in assessing liver function and bone metabolism. Clinically, elevated ALP levels are often associated with liver diseases such as cholestasis, hepatitis, and liver cirrhosis, as well as bone disorders like Paget's disease and osteomalacia. Conversely, low ALP levels may indicate conditions such as hypophosphatasia, a rare metabolic bone disease. For athletes and biohackers, monitoring ALP can provide insights into liver and bone health, which are critical for optimal performance and longevity. However, researchers observed that ALP levels can be influenced by factors such as age, sex, and certain medications, which may confound results. Therefore, it is important to interpret ALP levels in conjunction with other clinical findings and consider potential interfering factors such as recent meals or medications.
Klinische Bedeutung
Elevated ALP levels may indicate liver or bone disorders, while reduced levels can suggest conditions like hypophosphatasia. It is important for diagnosing liver diseases and bone metabolism disorders.
Progressively rising ALP levels suggest worsening liver or bone pathology. Retesting is recommended within 4 weeks if levels are outside the optimal range.
Falling ALP levels may indicate improvement in liver or bone conditions or could suggest hypophosphatasia if levels drop significantly.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before starting any supplementation, especially if underlying conditions are present.
Testing Frequency
Annually for healthy adults, more frequently if monitoring liver or bone conditions.
Correlated with
Current research suggests that reference ranges for alkaline phosphatase (ALP) may vary significantly with age and sex, leading to potential misinterpretations, particularly in children. Researchers have not yet established optimal targets for ALP isoenzyme patterns in diagnosing specific liver and bone diseases. Additionally, clinical questions remain unanswered regarding the differential diagnosis of overlapping ALP values in conditions like hypophosphatasia and the implications of various isoenzyme patterns in malignancies and renal diseases.
683
Total Citations
6
Human/RCT
1.7
Avg. Influence
2024
Latest
Van Hoof V O & De Broe M E · Critical reviews in clinical laboratory sciences · 1994
This review focused on alkaline phosphatase (ALP) isoenzymes and their clinical significance. Researchers found that different isoenzyme patterns can provide valuable diagnostic information for liver and bone diseases. The study emphasizes the importance of correctly interpreting ALP isoenzyme patterns for effective patient management.
Key findings
This review focused on recent developments in fluorescence strategies for detecting alkaline phosphatase (ALP). Researchers observed that abnormal ALP levels are associated with many diseases, and innovative detection methods are needed for precision medicine. The study discussed future trends in ALP detection technology.
This review examined alkaline phosphatase as a potential biomarker for stroke, discussing its biological role and isoenzyme variations. Researchers noted that while ALP has been evaluated in various disorders, its utility as a stroke biomarker remains under investigation. The review suggests exploring ALP-targeted treatments for stroke patients.
This paper reviewed optical and electrochemical biosensors for detecting alkaline phosphatase (ALP). Researchers found that abnormal ALP levels are linked to various diseases, making reliable assay methods crucial for clinical diagnoses. The review discussed strategies for improving ALP detection in biomedical research.
This review discussed the role of interleukin-17 in acute pancreatitis, highlighting its impact on immune response and inflammation. Researchers observed that targeting IL-17 could potentially alleviate the severity of acute pancreatitis. The review emphasizes the need for further research into therapeutic strategies involving IL-17.
This review focused on the role of alkaline phosphatase in diagnosing rickets in children. Researchers found that elevated ALP levels are indicative of bone formation and are crucial for differentiating rickets from other disorders. The study emphasizes the importance of ALP measurements in clinical follow-up and treatment.
This article reviewed tracking solutions in anatomic pathology laboratories, emphasizing their potential to enhance efficiency and patient safety. Researchers noted that successful implementation requires careful analysis of laboratory workflows and cultural changes within the laboratory. The study highlights the importance of training and accountability in adopting new technologies.
This study examined the classification of liver enzymes in horses, focusing on alkaline phosphatase (ALP) as a marker for chronic liver disease. Researchers found that ALP levels, along with other liver enzymes, can indicate different types of liver pathologies and their progression. The study emphasizes the importance of evaluating enzyme patterns for accurate diagnosis.
This study explored the relationship between primary hyperparathyroidism (PHPT) and pancreatitis, finding that PHPT patients with pancreatitis had significantly higher serum alkaline phosphatase levels. Researchers noted that pancreatitis can be the only presenting symptom of PHPT, suggesting the need for thorough investigation in such cases. After treatment, most patients did not experience further pancreatitis episodes.
This systematic review examined the use of fMRI connectivity as a biomarker for antipsychotic treatment response. Researchers found high variability in study results, indicating the need for methodological uniformity. The review suggested that fMRI connectivity could potentially predict treatment response in psychosis.
Research publications about Alkalische Phosphatase over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer